期刊文献+

抗精神病新药阿立哌唑的合成 被引量:2

Synthesis of antipsychotic aripiprazole
下载PDF
导出
摘要 目的合成阿立哌唑并考察优化中间体合成工艺。方法采用7-羟基-3,4-二氢-2(1H)-喹诺酮为起始原料,在碳酸钾存在下,与1,4-二溴丁烷发生醚化生成中间体7-(4-溴丁氧基)-3,4-二氢-2(1H)一喹诺酮(2),在KI和TBAB催化下,继续与N-(2,3-二氯苯基)哌嗪盐酸盐反应,制得目标产物阿立哌唑(1)。在此基础上,对中间体2的合成工艺进行考察,确立了最佳反应条件。结果中间体2和目标产物的结构均已由1H-NMR和MS确证,总收率为67.6%,熔点:139~140℃,与文献报道(139.0~140.0℃)相符。结论和文献报道方法相比,本工艺采用丙酮作为溶剂,代替了文献中采用的DMF溶剂,使合成成本大为降低;采用重结晶的方法进行中间体和目标化合物的纯化,取代了文献中采用的柱层析方法,使操作大为简化,合成工艺更适合于放大合成及工业化。此外,中间体2的合成工艺得到优化后,收率比文献提高了近10%;总收率比文献提高5%. Objective To prepare aripiprazole( 1 ) and optimize the synthetic process for the intermediate 7- (4-bromobutoxy) -3,4-dihydro-2 (1H) -quinolone (2). Methods 7-Hydroxy-3,4-dihydro-2 (1H) -quinolone reacted with potassium carbonate and 1,4-dibromobutane via etherification to give 2. And then 2 reacted with potassium carbonate and 1- (2,3-dichlorophenyl) piperazine hydrochloride under the catalysis of potas- sium iodide and TBAB to give the target product 1. The synthetic process was researched and the reaction conditions were optimized. Results The structures of intermediate 2 and target 1 had been characterized by IR and 1H-NMR. The overall yield was 67.6%. The mp( 139- 140 ℃ ) of product 1 is consistent with the that (139.0-140.0℃ )reported in the literature. Conclusions Compare with the previous methods in the lit- eratures,this synthesis process was improved by changing the reaction solvent from DMF to acetone to in- crease the purity of 2. Compound 1 could be obtained by recrystallization once instead of separation on col- umns. The changes can reduce the costs and simplify the experimental operations. Besides, through impro- ving the procedureis of intermediate 2, the overall yield is superior 5 % and the yield of intermediate 2 is su- perior 10% to the literatures's,respectively.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2013年第4期253-255,共3页 Journal of Shenyang Pharmaceutical University
关键词 阿立哌唑 抗精神病药物 合成 工艺优化 aripiprazole antipsychotics synthesis process improvement
  • 相关文献

参考文献6

  • 1吴仁容,李乐华.新型抗精神病药:阿立哌唑[J].国外医学(精神病学分册),2004,31(3):177-179. 被引量:380
  • 2KIKUCHI T, TOTrORI K, UWAHODO Y, et al. Pharmacological effects of aripiprazole ( OPC - 14597 ), a novel antisopsychotic drug [ J ]. Shinker Seishin Yakufi,1995,17(10) : 719 -722.
  • 3OSHIRO Y, SATO S, KURAHASHI N, et al. Novel antipsychotic agents with dopamine autoreceptor ago- nist properties: synthesis and pharmacology of 7-E 4- ( 4-pheny-1 -piperazinyl) butoxyl ] -3,4-dihydro-2 ( 1H ) - quinolinone [ J ]. J Med Chem, 1998,41 ( 5 ) : 658 - 667.
  • 4大城靖男,佐藤诚司,仓桥伸幸.制备喹诺酮衍生物的方法:中国,1042537[P].1990-05-30.(CA 1990,113:152468)
  • 5张桂森,朱永超,马彦琴.阿立哌唑的合成[J].中国医药工业杂志,2006,37(10):655-656. 被引量:5
  • 6张鸿燕,马弘.阿立哌唑[J].中国新药杂志,2003,12(10):868-869. 被引量:103

二级参考文献32

  • 1王军玲,贾湘曼,鲍春和,陈子明,蒋晔.阿立哌唑的合成[J].中国医药工业杂志,2004,35(12):707-708. 被引量:10
  • 2张璞,李中东,焦正.第二代非典型抗精神病药——阿立哌唑[J].中国药学杂志,2005,40(3):238-240. 被引量:58
  • 3Kilkuchiet T,et al:J Pharmacol Exp Ther.1995;274(1):329—336.
  • 4Semba J,et al:Neuropharmacology,1995;34(7):785—791.
  • 5Fujikawa M,et al:Pharmacol Biochem Behav.1996;53(4):903—909.
  • 6Alison P,et al:Molecular Brain Research,1998;55:285—292.
  • 7Inoue A。et al:Brain Res Mol Brain Res.1998;55:285—292.
  • 8Shapine DA,et al:Neuropsychopharmacology,2003:1 46(5):214—216.
  • 9Bruce S:Drugs Research and Development,1999;2(1):47—48.
  • 10Stephen M,et al:Drugs oI the Future,2000;25(9):961—963.

共引文献457

同被引文献20

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部